| 000 | 01389 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515015606.0 | ||
| 264 | 0 | _c20060724 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0926-9959 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2006.01432.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaya, T I | |
| 245 | 0 | 0 |
_aUltraviolet recall phenomenon associated with methotrexate and cytarabine. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cMar 2006 |
||
| 300 |
_a353-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aArm |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aUltraviolet Rays _xadverse effects |
| 700 | 1 | _aTiftik, N | |
| 700 | 1 | _aTursen, U | |
| 700 | 1 | _aIkizoglu, G | |
| 700 | 1 | _aYalcin, A | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 20 _gno. 3 _gp. 353-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2006.01432.x _zAvailable from publisher's website |
| 999 |
_c16114539 _d16114539 |
||